These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2671289)

  • 61. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
    von Heyden HW; Schröder M; Scherpe A; Stennert E; Beyer JH; Nagel GA; Hoffmann H; Schneider B
    HNO; 1984 Nov; 32(11):454-9. PubMed ID: 6210278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L
    J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck.
    Lustig RA; DeMare PA; Kramer S
    Cancer; 1976 Jun; 37(6):2703-8. PubMed ID: 949688
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase II trial of carboplatin and tegafur (Ftorafur) as induction therapy in squamous-cell carcinoma of the head and neck.
    Gonzalez-Baron M; Vicente J; Martin G; Artal A; Cebreiros I; Garcia-Giron C; Tomas M; Gavilan J; Martorell V; Zamora P
    Am J Clin Oncol; 1990 Aug; 13(4):277-9. PubMed ID: 2116084
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.
    Hitchins RN; Bell DR; Woods RL; Levi JA
    J Clin Oncol; 1987 Oct; 5(10):1655-62. PubMed ID: 3309199
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancer.
    DeConti RC; Schoenfeld D
    Cancer; 1981 Sep; 48(5):1061-72. PubMed ID: 7023649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.
    Woods JE; DeSanto LW; Ritts RE
    Surg Clin North Am; 1977 Aug; 57(4):769-78. PubMed ID: 897965
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Importance of AUC of carboplatin in head and neck cancer].
    Shimizu T; Yoshida M; Makishima K
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Mar; 101(3):259-65. PubMed ID: 9584464
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
    Vokes EE; Dimery IW; Jacobs CD; Karp D; Molina A; Collier MA; Eble ML; Clendeninn NJ
    Cancer; 1991 May; 67(9):2253-7. PubMed ID: 2013031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chemotherapy of advanced head and neck cancer: updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracil.
    Mackintosh JF; Coates AS; Tattersall MH; Swanson C
    Med Pediatr Oncol; 1988; 16(5):304-7. PubMed ID: 3054452
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate-5-fluorouracil chemotherapy in head and neck cancer.
    Browman GP; Levine MN; Russell R; Young JE; Archibald SD
    Head Neck Surg; 1986; 8(3):146-52. PubMed ID: 3528055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
    Pitman SW; Miller D; Weichselbaum R
    Laryngoscope; 1978 Apr; 88(4):632-8. PubMed ID: 306011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systemic high-dose intravenous methotrexate for central nervous system metastases.
    Lassman AB; Abrey LE; Shah GD; Panageas KS; Begemann M; Malkin MG; Raizer JJ
    J Neurooncol; 2006 Jul; 78(3):255-60. PubMed ID: 16344918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Result of two randomized trials comparing nolatrexed (Thymitaq) versus methotrexate in patients with recurrent head and neck cancer.
    Pivot X; Wadler S; Kelly C; Ruxer R; Tortochaux J; Stern J; Belpomme D; Humblet Y; Domenge C; Clendeninn N; Johnston A; Penning C; Schneider M
    Ann Oncol; 2001 Nov; 12(11):1595-9. PubMed ID: 11822760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of recurrent and metastatic carcinoma of cervix: a comparison of low dose methotrexate with adriamycin plus methotrexate.
    Sabir AA; Khoury GG; Joslin CA; Head C
    Clin Oncol (R Coll Radiol); 1989 Nov; 1(2):70-4. PubMed ID: 2486483
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of second-line treatments of recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    El Rassy E; Assi T; Bakouny Z; El Karak F; Pavlidis N; Ghosn M
    Future Oncol; 2019 Mar; 15(8):909-923. PubMed ID: 30669875
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.
    Woods RL; Fox RM; Tattersall MH
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):600-2. PubMed ID: 6781586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyurea with cisdiamminedichloro-platinum plus methotrexate.
    Bezwoda WR; Nissenbaum M; Derman DP
    Med Pediatr Oncol; 1986; 14(1):17-9. PubMed ID: 3512970
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery.
    Ervin TJ; Kirkwood J; Weichselbaum RR; Miller D; Pitman SW; Frei E
    Laryngoscope; 1981 Jul; 91(7):1181-90. PubMed ID: 7017315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.